11
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60930 | CAXII-IN-1 | ||
CAXII-IN-1 (Compound 17) 具有抗肿瘤活性,它是 CA XII 的选择性抑制剂。CAXII-IN-1 对 hCA XII 和 hCA IX 的 Ki 值分别为 3.8 nM 和 56.0 nM。 | |||
T2017 |
U-104
NSC-213841,MST-104 |
Carbonic Anhydrase | Metabolism |
U-104 (NSC-213841) 是 CA IX 和 CA XII 碳酸酐酶 (CA) 抑制剂,其 Ki 分别为 45.1 nM 和 4.5 nM。小鼠模型中,它能够表现出明显的抑制肿瘤生长的作用。 | |||
T63973 |
hCAXII-IN-3
|
||
hCAXII-IN-3 (Compound 6o) 是人碳酸酐酶 XII(hCAXII)的选择性抑制剂 (Ki: 10.0 nM)。 | |||
T61769 | hCAXII-IN-5 | ||
hCAXII-IN-5 (compound 6o) is a highly effective and specific inhibitor of hCAXII. The compound exhibits impressive binding affinities, with Ki values of >10000, >10000, 286.1, and 1.0 nM for hCAI, hCAII, hCAIX, and hCAXII, respectively [1]. | |||
T63276 |
hCAXII-IN-4
|
||
hCAXII-IN-4 是选择性的、有效的 CA XII 抑制剂,对人CA XII 的Ki 值为 6.4 nM。 | |||
T62101 |
hCAXII-IN-2
|
||
hCAXII-IN-2 (compound 5i) 是一种人碳酸酐酶 XII (hCA XII) (Ki: 84.2 nM) 和 hCA IX (Ki: 268.5 nM) 的有效抑制剂,对 hCA I 和 hCA II 具有较低的活性。 | |||
T61219 |
hCAXII-IN-1
|
||
hCAXII-IN-1 demonstrates selective inhibition of tumor-related subtypes HCA IX and XII, making it potential leading molecules in the development of novel cancer therapeutic drugs with new mechanisms of action. | |||
T79411 |
hCAXII-IN-7
|
Carbonic Anhydrase | Metabolism |
hCAXII-IN-7 (compound 6e)为hCA XII抑制剂,且具备脑屏障通透性。此化合物能够诱导786-0、SF-539和HS 578 T细胞系的凋亡。 | |||
T61384 |
hCAIX/XII-IN-4
|
||
hCAIX/XII-IN-4 (compound 6c) is a highly potent inhibitor of CAIX/XII. It exhibits Ki values of 4.5 nM, 23.6 nM, >10000 nM, and >10000 nM for CAXII, CAIX, CAI, and CAⅡ, respectively [1]. | |||
T61873 | hCAIX/XII-IN-1 | ||
hCAIX/XII-IN-1 是一种有效的CAIX/XII 抑制剂,KI 值分别为 0.48 μM 和 0.83 μM。hCAIX/XII-IN-1 显示出体外抗增殖活性。hCAIX/XII-IN-1 诱导 MCF-7 细胞凋亡apoptosis。 | |||
T36059 |
Dichlorphenamide-13C6
Dichlorphenamide-13C6 |
||
Dichlorphenamide-13C6is intended for use as an internal standard for the quantification of dichlorphenamide by GC- or LC-MS. Dichlorphenamide is a sulfonamide and an orally bioavailable carbonic anhydrase (CA) inhibitor (Kis = 1.20, 38, 50, and 50 nM for the human CA isoforms CAI, CAII, CAIX, and CAXII, respectively).1It lowers intraocular pressure in rabbits when 50 μl of a 10% solution is applied topically to the eye.2Dichlorphenamide rescues the potassium deficiency and prevents insulin-induc... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00694 |
Carbonic Anhydrase 12 Protein, Human, Recombinant (His)
HsT18816,FLJ20151,carbonic anhydrase XII,CA12,CAXII |
Human | HEK293 Cells |
Carbonic Anhydrase 12 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.6 kDa and the accession number is O43570-1. | |||
TMPY-06944 |
Carbonic Anhydrase 12 Protein, Human, Recombinant (His & Avi), Biotinylated
HsT18816,carbonic anhydrase XII,CAXII,FLJ20151,CA12 |
Human | HEK293 Cells |
Carbonic Anhydrase 12 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 33.45 kDa and the accession number is NP_001209.1. | |||
TMPK-00478 |
Carbonic Anhydrase 12 Protein, Cynomolgus, Recombinant (His)
CA12,CAXII,Carbonic anhydrase,CA-XII,Tumor antigen ... |
Cynomolgus | HEK293 Cells |
Carbonic anhydrases (CAs) are a family of enzymes involved in the pH regulation of metabolically active cells/tissues. Carbonic anhydrase XII (CA XII) is a key mediator of several signaling pathways that are involved in cancer development. |